Camerini A - Search Results

1

Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals.

Bisceglia I, Canale ML, Silvestris N, Gallucci G, Camerini A, Inno A, Camilli M, Turazza FM, Russo G, Paccone A, Mistrulli R, De Luca L, Di Fusco SA, Tarantini L, Lucà F, Oliva S, Moreo A, Maurea N, Quagliariello V, Ricciardi GR, Lestuzzi C, Fiscella D, Parrini I, Racanelli V, Russo A, Incorvaia L, Calabrò F, Curigliano G, Cinieri S, Gulizia MM, Gabrielli D, Oliva F, Colivicchi F. Bisceglia I, et al. Among authors: camerini a. Front Cardiovasc Med. 2023 Sep 15;10:1223660. doi: 10.3389/fcvm.2023.1223660. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37786510 Free PMC article. Review.

2

Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial).

Camerini A, Puccetti C, Donati S, Valsuani C, Petrella MC, Tartarelli G, Puccinelli P, Amoroso D. Camerini A, et al. BMC Cancer. 2015 May 6;15:359. doi: 10.1186/s12885-015-1354-2. BMC Cancer. 2015. PMID: 25943747 Free PMC article. Clinical Trial.

3

Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis.

Bracarda S, Iacovelli R, Boni L, Rizzo M, Derosa L, Rossi M, Galli L, Procopio G, Sisani M, Longo F, Santoni M, Morelli F, Di Lorenzo G, Altavilla A, Porta C, Camerini A, Escudier B; Rainbow Group. Bracarda S, et al. Among authors: camerini a. Ann Oncol. 2016 Feb;27(2):366. doi: 10.1093/annonc/mdv589. Epub 2015 Dec 18. Ann Oncol. 2016. PMID: 26685011 Free article. No abstract available.

4

Analysis of dystroglycan regulation and functions in mouse mammary epithelial cells and implications for mammary tumorigenesis.

Sgambato A, Di Salvatore MA, De Paola B, Rettino A, Faraglia B, Boninsegna A, Graziani C, Camerini A, Proietti G, Cittadini A. Sgambato A, et al. Among authors: camerini a. J Cell Physiol. 2006 May;207(2):520-9. doi: 10.1002/jcp.20600. J Cell Physiol. 2006. PMID: 16447256

5

Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer.

Mazzoni F, Cecere FL, Meoni G, Giuliani C, Boni L, Camerini A, Lucchesi S, Martella F, Amoroso D, Lucherini E, Torricelli F, Di Costanzo F. Mazzoni F, et al. Among authors: camerini a. Lung Cancer. 2013 Nov;82(2):288-93. doi: 10.1016/j.lungcan.2013.08.018. Epub 2013 Sep 3. Lung Cancer. 2013. PMID: 24045016 Clinical Trial.

6

Decreased expression of the CDK inhibitor p27Kip1 and increased oxidative DNA damage in the multistep process of cervical carcinogenesis.

Sgambato A, Zannoni GF, Faraglia B, Camerini A, Tarquini E, Spada D, Cittadini A. Sgambato A, et al. Among authors: camerini a. Gynecol Oncol. 2004 Mar;92(3):776-83. doi: 10.1016/j.ygyno.2003.12.008. Gynecol Oncol. 2004. PMID: 14984940

7

Aberrant expression of alpha-dystroglycan in cervical and vulvar cancer.

Sgambato A, Tarquini E, Resci F, De Paola B, Faraglia B, Camerini A, Rettino A, Migaldi M, Cittadini A, Zannoni GF. Sgambato A, et al. Among authors: camerini a. Gynecol Oncol. 2006 Nov;103(2):397-404. doi: 10.1016/j.ygyno.2006.03.059. Epub 2006 Jun 12. Gynecol Oncol. 2006. PMID: 16765426

8

Human mammaglobin transcript amplification for differential diagnosis in a breast cancer metastatic to dura mater.

Dono M, Ferro P, Franceschini MC, Dessanti P, Bacigalupo B, Cibei E, Capellini C, Amoroso D, Camerini A, Fedeli F, Roncella S. Dono M, et al. Among authors: camerini a. Anticancer Res. 2011 Mar;31(3):1061-4. Anticancer Res. 2011. PMID: 21498739

9

Loss of nuclear p27(kip1) and α-dystroglycan is a frequent event and is a strong predictor of poor outcome in renal cell carcinoma.

Sgambato A, Camerini A, Genovese G, De Luca F, Viacava P, Migaldi M, Boninsegna A, Cecchi M, Sepich CA, Rossi G, Arena V, Cittadini A, Amoroso D. Sgambato A, et al. Among authors: camerini a. Cancer Sci. 2010 Sep;101(9):2080-6. doi: 10.1111/j.1349-7006.2010.01644.x. Cancer Sci. 2010. PMID: 20626751 Free article.

10

Safety and activity of sunitinib in elderly patients (≥ 70 years) with metastatic renal cell carcinoma: a multicenter study.

Brunello A, Basso U, Sacco C, Sava T, De Vivo R, Camerini A, Barile C, Roma A, Maruzzo M, Falci C, Zagonel V. Brunello A, et al. Among authors: camerini a. Ann Oncol. 2013 Feb;24(2):336-342. doi: 10.1093/annonc/mds431. Epub 2012 Oct 9. Ann Oncol. 2013. PMID: 23051952 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page